PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical Engineering, University of Alberta, Edmonton, AB T6G 1Z2, Canada.\', \'Centre for Molecular Simulation, Department of Biological Sciences, University of Calgary, 2500 University Drive, Calgary, AB, T2N 1N4, Canada.\', \'Department of Medical Microbiology & Immunology, 6-010 Katz Group-Rexall Centre for Health Research, Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, T6G 2E1, Canada.\', \'Department of Biomedical Engineering, University of Alberta, Edmonton, AB T6G 1Z2, Canada. jackt@ualberta.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s40360-021-00519-5
?:doi
?:hasPublicationType
?:journal
  • BMC pharmacology & toxicology
is ?:pmid of
?:pmid
?:pmid
  • 34674775
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.785
?:rankingScore_hIndex
  • 19
?:title
  • Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34674775>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34674775>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all